Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

businesswire

CHICAGO –(BUSINESS WIRE) Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) clearance from the U.S. Food…

More Press Releases

Featured image for Auto-prepared featured image

April 30, 2026

Kharis Publishing Releases Against the Current: Following Jesus in a Nation Adrift – A Timely Pastoral Guide for Christians Navigating Faith, Politics, and a Divided America

April 30, 2026

Aurora Clinic Reveals Why Desk Workers Can’t Ignore Postural Pain

April 30, 2026

Midea Ceiling-Mounted “Pancake” Air Handler Delivers Inverter-Driven Technology and Performance in Multifamily HVAC Design

April 30, 2026

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Kharis Publishing Releases Against the Current: Following Jesus in a Nation Adrift – A Timely Pastoral Guide for Christians Navigating Faith, Politics, and a Divided America

Aurora Clinic Reveals Why Desk Workers Can’t Ignore Postural Pain

Midea Ceiling-Mounted “Pancake” Air Handler Delivers Inverter-Driven Technology and Performance in Multifamily HVAC Design

Mitek to Report Fiscal 2026 Second Quarter Financial Results on May 7, 2026